$97.73
0.340.35%
Last update: 2:05 PM
15 minutes delayed
Colgate-Palmolive
CLNYSE
want to know what
the Bulls & Bears Say?
Colgate-Palmolive (NYSE:CL) Stock, Analyst Ratings, Price Targets, Forecasts
Colgate-Palmolive Co has a consensus price target of $93.86 based on the ratings of 23 analysts. The high is $112 issued by Citigroup on July 10, 2024. The low is $80 issued by Atlantic Equities on May 3, 2022. The 3 most-recent analyst ratings were released by Citigroup, B of A Securities, and Wells Fargo on July 10, 2024, respectively. With an average price target of $106.33 between Citigroup, B of A Securities, and Wells Fargo, there's an implied 9.19% upside for Colgate-Palmolive Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
B of A Securities
Wells Fargo
Exane BNP Paribas
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Colgate-Palmolive
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | Buy Now | 15.01% | Citigroup | Filippo Falorni | $103 → $112 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 12.96% | B of A Securities | Bryan Spillane | $100 → $110 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | -0.39% | Wells Fargo | Chris Carey | $92 → $97 | Maintains | Equal-Weight | Get Alert |
| 06/24/2024 | Buy Now | 11.93% | Exane BNP Paribas | Kevin Grundy | → $109 | Initiates | → Outperform | Get Alert |
| 05/28/2024 | Buy Now | 5.77% | Morgan Stanley | Dara Mohsenian | $101 → $103 | Maintains | Overweight | Get Alert |
| 05/15/2024 | Buy Now | 9.88% | Argus Research | Chris Graja | $97 → $107 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | -12.71% | Barclays | Lauren Lieberman | $84 → $85 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | Buy Now | -5.52% | Wells Fargo | Chris Carey | $90 → $92 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | Buy Now | -2.44% | Stifel | Mark Astrachan | $94 → $95 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | 2.69% | B of A Securities | Bryan Spillane | $90 → $100 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | -2.44% | RBC Capital | Nik Modi | $88 → $95 | Maintains | Sector Perform | Get Alert |
| 04/16/2024 | Buy Now | 2.69% | Citigroup | Filippo Falorni | $95 → $100 | Maintains | Buy | Get Alert |
| 04/12/2024 | Buy Now | -13.74% | Barclays | Lauren Lieberman | $82 → $84 | Maintains | Equal-Weight | Get Alert |
| 04/10/2024 | Buy Now | -3.47% | Stifel | Mark Astrachan | $89 → $94 | Maintains | Buy | Get Alert |
| 04/08/2024 | Buy Now | -1.42% | Evercore ISI Group | Robert Ottenstein | $90 → $96 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | -4.5% | Goldman Sachs | Jason English | → $93 | Reinstates | → Buy | Get Alert |
| 01/29/2024 | Buy Now | -4.5% | Morgan Stanley | Dara Mohsenian | $85 → $93 | Maintains | Overweight | Get Alert |
| 01/29/2024 | Buy Now | -2.44% | UBS | Peter Grom | $93 → $95 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | -9.63% | Wells Fargo | Chris Carey | $80 → $88 | Maintains | Equal-Weight | Get Alert |
| 01/29/2024 | Buy Now | -6.55% | Raymond James | Olivia Tong | → $91 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/18/2024 | Buy Now | -7.58% | JP Morgan | Andrea Teixeira | $88 → $90 | Maintains | Overweight | Get Alert |
| 01/16/2024 | Buy Now | -15.79% | Barclays | Lauren Lieberman | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 12/15/2023 | Buy Now | -7.58% | B of A Securities | Bryan Spillane | → $90 | Upgrade | Neutral → Buy | Get Alert |
| 11/29/2023 | Buy Now | -9.63% | JP Morgan | Andrea Teixeira | $83 → $88 | Maintains | Overweight | Get Alert |
| 11/13/2023 | Buy Now | -10.66% | Jefferies | Kaumil Gajrawala | → $87 | Initiates | → Buy | Get Alert |
| 10/30/2023 | Buy Now | -17.85% | RBC Capital | Nik Modi | $79 → $80 | Maintains | Sector Perform | Get Alert |
| 10/30/2023 | Buy Now | -12.71% | Morgan Stanley | Dara Mohsenian | $89 → $85 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | -22.98% | B of A Securities | Bryan Spillane | $85 → $75 | Maintains | Neutral | Get Alert |
| 10/16/2023 | Buy Now | -16.82% | Stifel | Mark Astrachan | $85 → $81 | Upgrade | Hold → Buy | Get Alert |
| 10/12/2023 | Buy Now | -25.04% | Barclays | Lauren Lieberman | $81 → $73 | Maintains | Equal-Weight | Get Alert |
| 10/12/2023 | Buy Now | -16.82% | JP Morgan | Andrea Teixeira | $85 → $81 | Maintains | Overweight | Get Alert |
| 10/11/2023 | Buy Now | -12.71% | Citigroup | Filippo Falorni | $92 → $85 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | -13.74% | HSBC | Alejandro Zamacona | → $84 | Initiates | → Buy | Get Alert |
| 08/01/2023 | Buy Now | -16.82% | Barclays | Lauren Lieberman | $77 → $81 | Maintains | Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | -14.77% | RBC Capital | Nik Modi | → $83 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 07/31/2023 | Buy Now | -6.55% | Deutsche Bank | Steve Powers | $88 → $91 | Maintains | Buy | Get Alert |
| 05/01/2023 | Buy Now | -12.71% | B of A Securities | Bryan Spillane | $80 → $85 | Maintains | Neutral | Get Alert |
| 05/01/2023 | Buy Now | -6.55% | Evercore ISI Group | Robert Ottenstein | $85 → $91 | Maintains | Outperform | Get Alert |
| 05/01/2023 | Buy Now | -14.77% | RBC Capital | Nik Modi | $82 → $83 | Maintains | Sector Perform | Get Alert |
| 05/01/2023 | Buy Now | -1.42% | Goldman Sachs | Jason English | $86 → $96 | Maintains | Buy | Get Alert |
| 05/01/2023 | Buy Now | -8.61% | Morgan Stanley | Dara Mohsenian | $82 → $89 | Maintains | Overweight | Get Alert |
| 05/01/2023 | Buy Now | -16.82% | Wells Fargo | Chris Carey | $76 → $81 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | -5.52% | Citigroup | Filippo Falorni | $88 → $92 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | -11.69% | UBS | Peter Grom | $84 → $86 | Maintains | Buy | Get Alert |
| 03/20/2023 | Buy Now | -17.85% | Deutsche Bank | Steve Powers | $84 → $80 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | -13.74% | Citigroup | Filippo Falorni | → $84 | Initiates | → Buy | Get Alert |
| 01/31/2023 | Buy Now | -20.93% | Barclays | Lauren Lieberman | $80 → $77 | Maintains | Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | -21.96% | Wells Fargo | Chris Carey | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | -15.79% | Morgan Stanley | Dara Mohsenian | → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/13/2023 | Buy Now | -11.69% | JP Morgan | Andrea Teixeira | $81 → $86 | Maintains | Overweight | Get Alert |
| 01/03/2023 | Buy Now | -17.85% | Wells Fargo | Chris Carey | $75 → $80 | Maintains | Equal-Weight | Get Alert |
| 12/06/2022 | Buy Now | -10.66% | Deutsche Bank | Steve Powers | $85 → $87 | Maintains | Buy | Get Alert |
| 11/22/2022 | Buy Now | — | Wolfe Research | Greg Badishkanian | — | Initiates | → Peer Perform | Get Alert |
| 11/01/2022 | Buy Now | -21.96% | Barclays | Lauren Lieberman | $72 → $76 | Maintains | Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | -12.71% | Credit Suisse | Kaumil Gajrawala | $88 → $85 | Maintains | Outperform | Get Alert |
| 10/17/2022 | Buy Now | -12.71% | Deutsche Bank | Steve Powers | $87 → $85 | Maintains | Buy | Get Alert |
| 10/13/2022 | Buy Now | -18.87% | JP Morgan | Andrea Teixeira | → $79 | Upgrade | Neutral → Overweight | Get Alert |
| 10/10/2022 | Buy Now | -16.82% | Goldman Sachs | Jason English | $91 → $81 | Maintains | Buy | Get Alert |
| 10/03/2022 | Buy Now | -22.98% | Wells Fargo | Chris Carey | $80 → $75 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | -24.01% | Barclays | Lauren Lieberman | $71 → $74 | Maintains | Equal-Weight | Get Alert |
| 08/01/2022 | Buy Now | -7.58% | UBS | Peter Grom | $88 → $90 | Maintains | Buy | Get Alert |
| 08/01/2022 | Buy Now | -17.85% | Wells Fargo | Chris Carey | $71 → $80 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 07/21/2022 | Buy Now | -19.9% | JP Morgan | Andrea Teixeira | $79 → $78 | Maintains | Neutral | Get Alert |
| 05/23/2022 | Buy Now | -27.09% | Barclays | Lauren Lieberman | $77 → $71 | Maintains | Equal-Weight | Get Alert |
| 05/03/2022 | Buy Now | -20.93% | Barclays | Lauren Lieberman | $81 → $77 | Maintains | Equal-Weight | Get Alert |
| 05/03/2022 | Buy Now | -17.85% | Atlantic Equities | Edward Lewis | $92 → $80 | Downgrade | Overweight → Neutral | Get Alert |
| 05/02/2022 | Buy Now | -9.63% | Deutsche Bank | Steve Powers | $91 → $88 | Maintains | Buy | Get Alert |
| 05/02/2022 | Buy Now | -15.79% | Morgan Stanley | Dara Mohsenian | $91 → $82 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | Buy Now | -15.79% | RBC Capital | Nik Modi | $84 → $82 | Maintains | Sector Perform | Get Alert |
| 04/13/2022 | Buy Now | -6.55% | Deutsche Bank | Steve Powers | $90 → $91 | Maintains | Buy | Get Alert |
| 04/08/2022 | Buy Now | — | Raymond James | Olivia Tong | — | Initiates | → Market Perform | Get Alert |
| 04/01/2022 | Buy Now | -16.82% | Barclays | Lauren Lieberman | $90 → $81 | Maintains | Equal-Weight | Get Alert |
| 03/30/2022 | Buy Now | -16.82% | JP Morgan | Andrea Teixeira | $86 → $81 | Maintains | Neutral | Get Alert |
| 02/02/2022 | Buy Now | -14.77% | Bernstein | Callum Elliott | $77 → $83 | Upgrade | Underperform → Market Perform | Get Alert |
| 01/31/2022 | Buy Now | -7.58% | Credit Suisse | Kaumil Gajrawala | $95 → $90 | Maintains | Outperform | Get Alert |
| 01/31/2022 | Buy Now | -6.55% | Morgan Stanley | Dara Mohsenian | $90 → $91 | Maintains | Equal-Weight | Get Alert |
| 12/16/2021 | Buy Now | — | Redburn Partners | Chris Pitcher | — | Initiates | → Neutral | Get Alert |
| 11/02/2021 | Buy Now | -14.77% | Barclays | — | — | Maintains | Equal-Weight | Get Alert |
| 11/01/2021 | Buy Now | -12.71% | RBC Capital | Nik Modi | — | Maintains | Sector Perform | Get Alert |
| 09/20/2021 | Buy Now | -11.69% | Deutsche Bank | Steve Powers | — | Upgrade | Hold → Buy | Get Alert |
| 08/02/2021 | Buy Now | -13.74% | Deutsche Bank | Steve Powers | — | Maintains | Hold | Get Alert |
FAQ
What is the target price for Colgate-Palmolive (CL) stock?
The latest price target for Colgate-Palmolive (NYSE:CL) was reported by Citigroup on July 10, 2024. The analyst firm set a price target for $112.00 expecting CL to rise to within 12 months (a possible 14.60% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Colgate-Palmolive (CL)?
The latest analyst rating for Colgate-Palmolive (NYSE:CL) was provided by Citigroup, and Colgate-Palmolive maintained their buy rating.
When was the last upgrade for Colgate-Palmolive (CL)?
The last upgrade for Colgate-Palmolive Co happened on January 29, 2024 when Raymond James raised their price target to $91. Raymond James previously had a market perform for Colgate-Palmolive Co.
When was the last downgrade for Colgate-Palmolive (CL)?
The last downgrade for Colgate-Palmolive Co happened on May 3, 2022 when Atlantic Equities changed their price target from $92 to $80 for Colgate-Palmolive Co.
When is the next analyst rating going to be posted or updated for Colgate-Palmolive (CL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Colgate-Palmolive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Colgate-Palmolive was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
Is the Analyst Rating Colgate-Palmolive (CL) correct?
While ratings are subjective and will change, the latest Colgate-Palmolive (CL) rating was a maintained with a price target of $103.00 to $112.00. The current price Colgate-Palmolive (CL) is trading at is $97.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.